Carlisle Companies Incorporated (CSL)

Financial leverage ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Total assets US$ in thousands 5,816,600 6,620,000 7,222,000 7,246,800 5,866,400
Total stockholders’ equity US$ in thousands 2,463,300 2,829,000 3,024,400 2,629,500 2,537,700
Financial leverage ratio 2.36 2.34 2.39 2.76 2.31

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $5,816,600K ÷ $2,463,300K
= 2.36

The financial leverage ratio of Carlisle Companies Incorporated has shown some fluctuations over the past five years. In 2020, the ratio stood at 2.31, indicating that the company used $2.31 of debt for every $1 of equity. This ratio increased to 2.76 by the end of 2021, suggesting a higher level of leverage compared to the previous year.

However, in 2022, the financial leverage ratio decreased to 2.39, indicating a reduction in the company's reliance on debt financing. By the end of 2023, the ratio further decreased to 2.34, suggesting a continued trend towards lower leverage. In 2024, the ratio increased slightly to 2.36, indicating a modest uptick in leverage.

Overall, the fluctuations in Carlisle Companies Incorporated's financial leverage ratio over the past five years suggest that the company has been actively managing its capital structure and adjusting its debt levels relative to equity. It is essential for stakeholders to monitor this ratio to assess the company's long-term solvency and financial risk.


Peer comparison

Dec 31, 2024

Company name
Symbol
Financial leverage ratio
Carlisle Companies Incorporated
CSL
2.36
West Pharmaceutical Services Inc
WST
1.36